ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Landscapes and dynamic diversifications of B-cell receptor repertoires in COVID-19 patients

Xiang, Haitao; Zhao, Yingze; Li, Xinyang; Liu, Peipei; Wang, Longlong; Wang, Meiniang; Tian, Lei; Sun, Hai-Xi; Zhang, Wei; Xu, Ziqian; Ye, Beiwei; Yuan, Xiaoju; Wang, Pengyan; Zhang, Ning; Gong, Yuhuan; Bian, Chengrong; Wang, Zhaohai; Yu, Linxiang; Yan, Jin; Meng, Fanping; Bai, Changqing; Wang, Xiaoshan; Liu, Xiaopan; Gao, Kai; Wu, Liang; Liu, Longqi; Gu, Ying; Bi, Yuhai; Shi, Yi; Zhang, Shaogeng; Zhu, Chen; Xu, Xun; Wu, Guizhen; Gao, George F.; Yang, Naibo; Liu, William J.; Yang, Penghui中国科学院研究生院; 深圳华大基因研究院; 中国科学院; 5
Human Immunology2022-2DOI: 10.1016/j.humimm.2021.10.007
8被引4阅读
引用收藏
分享

摘要

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused the pandemic of coronavirus disease 2019 (COVID-19). Great international efforts have been put into the development of prophylactic vaccines and neutralizing antibodies. However, the knowledge about the B cell immune response induced by the SARS-CoV-2 virus is still limited. Here, we report a comprehensive characterization of the dynamics of immunoglobin heavy chain (IGH) repertoire in COVID-19 patients. By using next-generation sequencing technology, we examined the temporal changes in the landscape of the patient's immunological status and found dramatic changes in the IGH within the patient's immune system after the onset of COVID-19 symptoms. Although different patients have distinct immune responses to SARS-CoV-2 infection, by employing clonotype overlap, lineage expansion, and clonotype network analyses, we observed a higher clonotype overlap and substantial lineage expansion of B cell clones 2-3 weeks after the onset of illness, which is of great importance to B-cell immune responses. Meanwhile, for preferences of V gene usage during SARS-CoV-2 infection, IGHV3-74 and IGHV4-34, and IGHV4-39 in COVID-19 patients were more abundant than those of healthy controls. Overall, we present an immunological resource for SARS-CoV-2 that could promote both therapeutic development as well as mechanistic research.

学科与关键词

关键词
COVID-19SARS-CoV-2B-cell receptor repertoireClonal expansion
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Human Immunology
发表日期
2022-02
卷期
第 83 卷, 第 2 期
页码
119-129
DOI
10.1016/j.humimm.2021.10.007
语言
ENGLISH
期刊等级
4区
成果收录
SCIE
资助标注
China National Gene-Bank; CAMS Research Units of Adaptive Evolution and Control of Emerging Viruses [2018RU009]; Excellent Young Scientist Program of the National Natural Science Foundation of China (NSFC) [81822040]; Beijing New-star Plan of Science and Technology [Z181100006218080]; Guangdong Provincial Key Laboratory of Genome Read and Write [2017B030301011]; Shenzhen Science and Technology Innovation Fund [JCYJ20170412152916724, JCYJ20170817145305022]; Zhongnanshan Medical Foundation of Guangdong Province [ZNSA-2021004]; COVID-19 Prevention and Treatment Fund from Shantou Science and Technology Agency

作者

  • X

    Xiang, Haitao (第一作者)

    bgi shenzhen · univ chinese acad sci

  • Z

    Zhao, Yingze

    chinese ctr dis control & prevent, natl inst viral dis control & prevent

查看全部 37 位作者收起作者
  • L

    Li, Xinyang

    bgi shenzhen · univ chinese acad sci

  • L

    Liu, Peipei

    chinese ctr dis control & prevent, natl inst viral dis control & prevent

  • W

    Wang, Longlong

    bgi shenzhen · univ chinese acad sci

  • W

    Wang, Meiniang

    bgi shenzhen

  • T

    Tian, Lei

    bgi shenzhen

  • S

    Sun, Hai-Xi

    bgi shenzhen

  • Z

    Zhang, Wei

    bgi shenzhen

  • X

    Xu, Ziqian

    chinese ctr dis control & prevent, natl inst viral dis control & prevent

  • Y

    Ye, Beiwei

    chinese ctr dis control & prevent, natl inst viral dis control & prevent

  • Y

    Yuan, Xiaoju

    chinese ctr dis control & prevent, natl inst viral dis control & prevent

  • W

    Wang, Pengyan

    chinese ctr dis control & prevent, natl inst viral dis control & prevent

  • Z

    Zhang, Ning

  • G

    Gong, Yuhuan

  • B

    Bian, Chengrong

    5 · peoples liberat army gen hosp

  • W

    Wang, Zhaohai

    5 · peoples liberat army gen hosp

  • Y

    Yu, Linxiang

    5 · peoples liberat army gen hosp

  • Y

    Yan, Jin

    5 · peoples liberat army gen hosp

  • M

    Meng, Fanping

    5 · peoples liberat army gen hosp

  • B

    Bai, Changqing

    5 · peoples liberat army gen hosp

  • W

    Wang, Xiaoshan

    bgi shenzhen

  • L

    Liu, Xiaopan

    bgi shenzhen · univ chinese acad sci

  • G

    Gao, Kai

    bgi shenzhen · univ chinese acad sci

  • W

    Wu, Liang

    bgi shenzhen

  • L

    Liu, Longqi

    bgi shenzhen

  • G

    Gu, Ying

    bgi shenzhen

  • B

    Bi, Yuhai

  • S

    Shi, Yi

  • Z

    Zhang, Shaogeng

    5 · peoples liberat army gen hosp

  • Z

    Zhu, Chen

    5 · peoples liberat army gen hosp

  • X

    Xu, Xun

    bgi shenzhen

  • W

    Wu, Guizhen

    chinese ctr dis control & prevent, natl inst viral dis control & prevent

  • G

    Gao, George F.

    chinese ctr dis control & prevent, natl inst viral dis control & prevent

  • Y

    Yang, Naibo

    bgi shenzhen · univ chinese acad sci

  • L

    Liu, William J.

    chinese ctr dis control & prevent, natl inst viral dis control & prevent

  • Y

    Yang, Penghui

    5 · peoples liberat army gen hosp

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417